Vertex Pharmaceuticals Company Info Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis. News & Analysis The Fool has written over 1,100 articles on Vertex Pharmaceuticals. Featured Article ...
A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Stay up to date with the latest Vertex Pharmaceuticals Incorporated stock price movements on Seeking Alpha's interactive chart. View comprehensive price data and historical prices on VRTX here.
Industry:Pharmaceuticals CEO:Reshma Kewalramani Website:https://www.vrtx.com/ Ticker:VRTX Company type:Public Revenues ($M):$9,869 Profits ($M):$3,620 Market value ($M):$107,975 Number of employees:5,236 Market value as of March 28, 2024.Vertex Pharmaceuticals stock chartVertex...
Vertex Pharmaceuticals Inc Stock Price Forecast for 2025April 2025460.010470.456459.231473.3462.22 % ▲ Vertex Pharmaceuticals Inc Stock Price Forecast for 2025May 2025470.572474.394469.740474.3940.81 % ▲ Vertex Pharmaceuticals Inc Stock Price Forecast for 2025June 2025472.035486.689470.912486.6893.01 % ▲ ...
VRTX Stock 12 Month Forecast $470.89 ▼(-4.07% Downside) Based on 22 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $470.89 with a high forecast of $555.00 and a low forecast of $325.00. The average price...
Get Vertex Pharmaceuticals Inc (VRTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Vertex Pharmaceuticals Incorporated - BOVESPA:VRTX34 - - - Multiples Valuation: Price / EPS 分享保存 股票价格 701.73 BRL 公允价值 482.40 BRL 看涨 -31.3% Price / LTM EPS Multiple Price / Fwd EPS Multiple Fair Value Benchmark Editor Select Price / LTM EPS Ratio Benchmark Companies ENZN ENTA...
The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $376.55, reflecting a +1.95% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 1.89%. At the sam
Get the latest updates on Vertex Pharmaceuticals Incorporated Common Stock (VRTX) pre market trades, share volumes, and more. Make informed investments with Nasdaq.